Successful desensitization to cloxacillin in a patient with sepsis, with infective endocarditis and clinical suspicion of hypersensitivity to penicillins, a case report

J Clin Pharm Ther. 2018 Dec;43(6):921-924. doi: 10.1111/jcpt.12751. Epub 2018 Jul 21.

Abstract

What is known and objective: Beta-lactam antibiotic (BLA) therapy is frequently needed to treat infective endocarditis (IE). Hypersensitive reactions to BLA restrict BLA therapy in allergic patients. In the current case, we aim to describe the utility of desensitization (DS) in this context. Although the evidence is limited, DS is recommended.

Case description: This case report deals with a 79-year-old woman with a clinical suspicion of allergy to BLA and a methicillin-sensitive Staphylococcus aureus (MSSA) IE. A cloxacillin DS protocol was developed to enable treatment with cloxacillin.

What is new and conclusion: Alternative antibiotic treatments may be less effective or not available in MSSA IE. In this case report, DS allowed optimal cloxacillin treatment.

Keywords: cloxacillin; desensitization; drug hypersensitivity; endocarditis; immunologic.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Anti-Bacterial Agents / administration & dosage*
  • Anti-Bacterial Agents / adverse effects
  • Anti-Bacterial Agents / immunology
  • Cloxacillin / administration & dosage*
  • Cloxacillin / adverse effects
  • Cloxacillin / immunology
  • Desensitization, Immunologic / methods
  • Drug Hypersensitivity / immunology
  • Endocarditis, Bacterial / drug therapy*
  • Endocarditis, Bacterial / microbiology
  • Female
  • Humans
  • Penicillins / adverse effects
  • Penicillins / immunology
  • Sepsis / drug therapy
  • Staphylococcal Infections / drug therapy*
  • Staphylococcal Infections / microbiology
  • Staphylococcus aureus / isolation & purification

Substances

  • Anti-Bacterial Agents
  • Penicillins
  • Cloxacillin